Gainers & Losers
Wed Dec 10 2025 09:55:49- Tata Steel share price
- ₹162.000.87%
- Sun Pharmaceutical Industr...
- ₹1,787.600.64%
- NTPC share price
- ₹321.650.58%
- ITC share price
- ₹403.100.56%
- HCL Technologies share price
- ₹1,664.050.38%
Active Stocks
Wed Dec 10 2025 10:29:43- Suzlon Energy share price
- ₹51.58-1.88%
- Yes Bank share price
- ₹21.73-1.32%
- Reliance Industries share price
- ₹1,535.300.43%
- Adani Power share price
- ₹141.20-0.56%
- Indian Oil Corporation share price
- ₹163.05-0.06%
Epigral Profit & Loss Annual
1,430.35 -16.05 (-1.11%)Updated : 10 Dec 2025
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 1,971.92 | 1,570.85 | 1,605.88 | 1,127.29 |
| Other Net | -4.19 | -10.86 | -15.40 | -13.10 |
| Diluted Weighted Average Shares | 4.22 | 4.16 | 4.16 | 4.16 |
| Gain( Loss)on Saleof Assets | 5.04 | -0.05 | 0.00 | -0.07 |
| Depreciation/ Amortization | 132.56 | 123.56 | 108.95 | 85.91 |
| Operating Income | 578.21 | 358.34 | 582.52 | 423.65 |
| Net Income | 357.69 | 195.87 | 353.29 | 252.79 |
| Income Availableto Com Excl Extra Ord | 357.69 | 195.87 | 353.29 | 252.79 |
| Other Operating Expenses Total | 126.50 | 99.19 | 90.84 | 104.83 |
| Net Income Before Taxes | 541.09 | 290.75 | 522.46 | 383.42 |
| Net Income After Taxes | 357.69 | 195.87 | 353.29 | 252.79 |
| Income Availableto Com Incl Extra Ord | 357.69 | 195.87 | 353.29 | 252.79 |
| Costof Revenue Total | 1,539.38 | 1,220.94 | 1,290.43 | 842.46 |
| Gross Profit | 1,010.75 | 708.25 | 897.97 | 708.48 |
| Interest Inc( Exp) Net- Non- Op Total | -37.97 | -56.68 | -44.65 | -27.05 |
| Diluted Net Income | 357.69 | 195.87 | 353.29 | 252.79 |
| DPS- Common Stock Primary Issue | 6.00 | 5.00 | 5.00 | - |
| Provisionfor Income Taxes | 183.40 | 94.88 | 169.17 | 130.64 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 357.69 | 195.87 | 353.29 | 252.79 |
| Total Revenue | 2,550.13 | 1,929.19 | 2,188.40 | 1,550.94 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 2,550.13 | 1,929.19 | 2,188.40 | 1,550.94 |
| Selling/ General/ Admin Expenses Total | 172.93 | 127.16 | 115.66 | 94.09 |
| Diluted Normalized EPS | 83.89 | 47.15 | 85.03 | 60.85 |
| Research Development | 0.55 | - | - | - |
| Diluted EPS Excluding Extra Ord Items | 84.68 | 47.14 | 85.03 | 60.84 |
*All figures in crores except per share values
Epigral Quick Links
Epigral Dividend Epigral Bonus Epigral News Epigral AGM Epigral Rights Epigral Splits Epigral Board Meetings Epigral Key Metrics Epigral Shareholdings Epigral Balance Sheet Epigral Cashflow Epigral Q1 Results Epigral Q2 Results Epigral Q3 Results Epigral Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
162.00+1.40(0.87%)
1,787.60+11.40(0.64%)
321.65+1.85(0.58%)
282.95-8.75 (-3.00%)
4,015.35-70.35 (-1.72%)